BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18422740)

  • 1. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
    Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Jung K
    Cancer Sci; 2008 Jun; 99(6):1188-94. PubMed ID: 18422740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
    Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
    Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
    Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Loening SA; Jung K
    Cancer Lett; 2008 Sep; 269(1):85-92. PubMed ID: 18504068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
    Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
    Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
    Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
    Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
    Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Belldegrun AS; Horvath S; Figlin RA
    J Urol; 2005 May; 173(5):1496-501. PubMed ID: 15821467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
    Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
    Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.
    Szarvas T; Becker M; vom Dorp F; Gethmann C; Tötsch M; Bánkfalvi A; Schmid KW; Romics I; Rübben H; Ergün S
    Cancer Sci; 2010 May; 101(5):1300-8. PubMed ID: 20180812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multivariate analysis of prognostic factors in renal cell carcinoma].
    Wang Y; Huang C; Wu Y; Gao G; Xin Y; Lin Z; Li X; Pan M
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):442-4. PubMed ID: 11832079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinoma.
    Richter EN; Oevermann K; Buentig N; Storkel S; Dallmann I; Atzpodien J
    J Urol; 2002 Aug; 168(2):460-4. PubMed ID: 12131288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
    Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
    Motzer RJ; Bacik J; Schwartz LH; Reuter V; Russo P; Marion S; Mazumdar M
    J Clin Oncol; 2004 Feb; 22(3):454-63. PubMed ID: 14752067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.